申请人:Incyte Corporation
公开号:US20180179202A1
公开(公告)日:2018-06-28
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.